UiPath, Inc. (PATH) Q1 2027 Earnings Call Transcript
UiPath NYSE: PATH reported a stronger-than-expected start to fiscal 2027, with management highlighting growth in annual recurring revenue, revenue and profitability, as well as increasing customer adoption of its artificial intelligence and process orchestration products.
While the top- and bottom-line numbers for UiPath (PATH) give a sense of how the business performed in the quarter ended April 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
UiPath (PATH) came out with quarterly earnings of $0.15 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.11 per share a year ago.
Evaluate the expected performance of UiPath (PATH) for the quarter ended April 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
In the most recent trading session, UiPath (PATH) closed at $10.73, indicating a +1.71% shift from the previous trading day.
PATH's ARR climbs from $1.38B to $1.85B through Q4 2026, signaling stronger enterprise automation adoption despite AI spending concerns.
PATH falls 25% in six months as investors weigh UiPath's AI orchestration potential against moderate growth and rising competition.
PATH's debt-free balance sheet and $1.47B cash position give it the flexibility to invest aggressively in AI, expansion and automation growth.
UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
In the closing of the recent trading day, UiPath (PATH) stood at $10.01, denoting a -6.1% move from the preceding trading day.
UiPath remains a Buy despite a 23% drop, as its automation leadership and AI integration underpin a resilient long-term thesis. PATH outperforms peers on growth and margins, boasts strong financial flexibility, and maintains a solid moat in automation software. Recent underperformance is attributed to macro risks—Middle East conflict, inflation, and higher rates—rather than company fundamentals.